Long-form essays, customer case studies, eval reports, and the occasional opinion from the team.
An honest look at our production failures, the architecture changes we made, and the numbers behind a 94% straight-through rate.
How a $480M biotech rebuilt its close cycle around four specialist agents.
Every Closora action is idempotent and reversible. Here is how, and why it matters for trust.
Per-seat economics break when an agent is the seat. A new pricing primitive for AI labor.
The streaming pipeline behind Closora’s AR collections agent.
A regional manufacturer ships a six-person procurement workflow as a single agent.
Acute, recurring, budgeted-for — and the auditor will tell you if you got it wrong.